Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.04
Shares Outstanding180.8M
Average Volume (10 days)1.8M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.62
Sales (TTM)$9.98
Book Value (MRQ)$17.92
Cash Flow (TTM)$0.49
Cash (MRQ)$4.77

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy15
 
Buy2
 
Hold3
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Jean-Jacques Bienaime
Director, Chief Executive Officer
(20,000)
Sell
May 8, 2020
Charles Greg Guyer
EVP, Chief Technical Officer
64,150
Acquire
May 4, 2020
Charles Greg Guyer
EVP, Chief Technical Officer
35,040
Acquire
May 4, 2020
Jean-Jacques Bienaime
Director, Chief Executive Officer
(5,000)
Sell
May 4, 2020
Jean-Jacques Bienaime
Director, Chief Executive Officer
(4,000)
Sell
May 1, 2020

Recent SEC Filings

Insider Buy/Sell
May 29, 2020
Insider Buy/Sell
May 29, 2020
Insider Buy/Sell
May 29, 2020
Insider Buy/Sell
May 29, 2020
Insider Buy/Sell
May 29, 2020

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information